{"id":"https://openalex.org/W2575705706","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.10108","title":"MORAb-003 inhibits folate-driven growth mediated by the human folate receptor alpha","display_name":"MORAb-003 inhibits folate-driven growth mediated by the human folate receptor alpha","alternate_titles":[],"publication_year":2006,"publication_date":"2006-06-20","ids":{"openalex":"https://openalex.org/W2575705706","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.10108","mag":"2575705706"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.24.18_suppl.10108","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.10108","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.10108","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2575705706"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071128283","display_name":"Eric Routhier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127606","display_name":"Morphotek (United States)","ror":"https://ror.org/02yq5yf84","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127606"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Routhier","raw_affiliation_strings":["Morphotek, Inc., Exton, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Morphotek, Inc., Exton, PA","institution_ids":["https://openalex.org/I4210127606"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014186637","display_name":"Howard A. Turchin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127606","display_name":"Morphotek (United States)","ror":"https://ror.org/02yq5yf84","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127606"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Turchin","raw_affiliation_strings":["Morphotek, Inc., Exton, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Morphotek, Inc., Exton, PA","institution_ids":["https://openalex.org/I4210127606"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079460373","display_name":"Rina K Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127606","display_name":"Morphotek (United States)","ror":"https://ror.org/02yq5yf84","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127606"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Patel","raw_affiliation_strings":["Morphotek, Inc., Exton, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Morphotek, Inc., Exton, PA","institution_ids":["https://openalex.org/I4210127606"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028927602","display_name":"Wolfgang Ebel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127606","display_name":"Morphotek (United States)","ror":"https://ror.org/02yq5yf84","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127606"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Ebel","raw_affiliation_strings":["Morphotek, Inc., Exton, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Morphotek, Inc., Exton, PA","institution_ids":["https://openalex.org/I4210127606"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038942427","display_name":"Philip M. Sass","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127606","display_name":"Morphotek (United States)","ror":"https://ror.org/02yq5yf84","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127606"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Sass","raw_affiliation_strings":["Morphotek, Inc., Exton, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Morphotek, Inc., Exton, PA","institution_ids":["https://openalex.org/I4210127606"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050422058","display_name":"Nicholas C. Nicolaides","orcid":"https://orcid.org/0000-0002-9456-2420","observed_orcids":["https://orcid.org/0000-0002-9456-2420"]},"institutions":[{"id":"https://openalex.org/I4210127606","display_name":"Morphotek (United States)","ror":"https://ror.org/02yq5yf84","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127606"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Nicolaides","raw_affiliation_strings":["Morphotek, Inc., Exton, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Morphotek, Inc., Exton, PA","institution_ids":["https://openalex.org/I4210127606"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083015075","display_name":"Luigi Grasso","orcid":"https://orcid.org/0000-0001-6559-2914","observed_orcids":["https://orcid.org/0000-0001-6559-2914"]},"institutions":[{"id":"https://openalex.org/I4210127606","display_name":"Morphotek (United States)","ror":"https://ror.org/02yq5yf84","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127606"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Grasso","raw_affiliation_strings":["Morphotek, Inc., Exton, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Morphotek, Inc., Exton, PA","institution_ids":["https://openalex.org/I4210127606"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210127606"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"18_suppl","first_page":"10108","last_page":"10108"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.5443999767303467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.5443999767303467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10499","display_name":"Folate and B Vitamins Research","score":0.2957000136375427,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0803999975323677,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.6029999852180481},{"id":"https://openalex.org/keywords/folate-receptor-alpha","display_name":"folate receptor alpha","score":0.9919999837875366},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9300000071525574},{"id":"https://openalex.org/keywords/5-methyltetrahydrofolate","display_name":"5-methyltetrahydrofolate","score":0.9340000152587891},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C175656101","wikidata":"https://www.wikidata.org/wiki/Q56646","display_name":"Chinese hamster ovary cell","level":3,"score":0.6960307359695435},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.6705633997917175},{"id":"https://openalex.org/C2780306303","wikidata":"https://www.wikidata.org/wiki/Q24784504","display_name":"Folate receptor","level":4,"score":0.655748188495636},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5559760928153992},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5323458313941956},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5077918171882629},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4983530044555664},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4974832832813263},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4840778410434723},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.46908465027809143},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4591803252696991},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.422443687915802},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4193165600299835},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.41508153080940247},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3642122745513916},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3418582081794739},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33117109537124634},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32414162158966064},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29002222418785095},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17368969321250916},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12630876898765564},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2006.24.18_suppl.10108","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.10108","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.10108","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2124979764","https://openalex.org/W1971057640","https://openalex.org/W2086818408","https://openalex.org/W2133212511","https://openalex.org/W2287062696","https://openalex.org/W153411300","https://openalex.org/W2916822238","https://openalex.org/W4233098978","https://openalex.org/W1842570318","https://openalex.org/W2336900569"],"abstract_inverted_index":{"10108":[0],"Background:":[1],"MORAb-003":[2,70,98,215],"is":[3,19,31,84],"a":[4,51,115,141,160,172,197,209],"therapeutic":[5],"humanized":[6],"antibody":[7],"currently":[8],"in":[9,57,81,86,177,208,224],"Phase":[10],"I":[11],"clinical":[12],"trials":[13],"for":[14],"advanced":[15],"ovarian":[16,41,92],"cancer,":[17],"and":[18,77,83],"directed":[20],"against":[21],"the":[22,35,38,165,178,218,225],"human":[23,91,221],"folate":[24,63,143,161,242],"receptor":[25],"alpha":[26],"(FR\u03b1),":[27],"an":[28],"antigen":[29],"which":[30,237],"highly":[32],"overexpressed":[33],"on":[34],"surface":[36,134],"of":[37,40,44,61,90,121,157,174,182,220,227,233],"majority":[39],"cancers.":[42],"Overexpression":[43],"FR\u03b1":[45,234],"has":[46],"been":[47],"shown":[48],"to":[49,54,118,132,190],"confer":[50],"growth":[52,228],"advantage":[53,229],"tumorigenic":[55],"cells":[56,129,137,187],"vitro,":[58,82],"under":[59,140,235],"conditions":[60,236],"reduced":[62,207],"availability.":[64],"We":[65,94],"have":[66],"previously":[67],"determined":[68],"that":[69,97],"elicits":[71],"robust":[72],"antibody-dependent":[73],"cellular":[74],"cytotoxicity":[75,79],"(ADCC)":[76],"complement-directed":[78],"(CDC)":[80],"effective":[85],"mouse":[87],"xenograft":[88],"models":[89],"cancer.":[93],"now":[95],"show":[96],"possesses":[99],"novel,":[100],"growth-inhibitory":[101],"functions":[102],"distinct":[103],"from":[104],"its":[105],"immune":[106],"effector":[107],"properties.":[108],"This":[109,202],"activity":[110,219],"can":[111,216],"be":[112,206],"recapitulated,":[113],"using":[114],"cell-based":[116],"assay":[117],"score":[119],"inhibition":[120],"folate-dependent":[122],"growth.":[123],"Methods:":[124],"Chinese":[125],"Hamster":[126],"Ovary":[127],"(CHO)":[128],"were":[130,138,188],"engineered":[131],"express":[133],"FR\u03b1.":[135,166],"The":[136],"cultured":[139],"low":[142],"(<":[144],"20":[145],"nM)":[146,241],"regimen,":[147],"then":[148],"re-fed":[149],"medium":[150],"supplemented":[151],"with":[152],"various":[153],"concentrations":[154],"(0\u201310":[155],"\u03bcM)":[156],"5-methyltetrahydrofolate":[158],"(5-MTF),":[159],"preferentially":[162],"internalized":[163],"by":[164,212,231],"Cellular":[167],"proliferation":[168,204],"was":[169],"measured":[170],"as":[171],"function":[173],"added":[175],"5-MTF,":[176],"presence":[179],"or":[180],"absence":[181],"MORAb-003.":[183,213],"Results:":[184],"FR\u03b1-expressing":[185],"CHO":[186],"found":[189],"require":[191],"approximately":[192],"100-fold":[193],"lower":[194],"5-MTF":[195],"than":[196],"matched,":[198],"non-expressing":[199],"cell":[200],"line.":[201],"increased":[203],"could":[205],"concentration-dependent":[210],"manner":[211],"Conclusions:":[214],"antagonize":[217],"FR\u03b1,":[222],"resulting":[223],"loss":[226],"conferred":[230],"overexpression":[232],"bracket":[238],"physiological":[239],"(10\u2013100":[240],"concentrations.":[243],"[Table:":[244],"see":[245],"text]":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2575705706","counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-01-26T00:00:00"}
